Dr Suresh Kumar R received his Ph.D. from University of Kerala for the thesis titled "Prognostic Relevance of Nucleophosmin1 and Methylation-Associated Gene Mutations in Acute Myeloid Leukaemia Patients." His doctoral research, conducted at the Laboratory of Cytogenetics, Regional Cancer Centre, Trivandrum, focused on elucidating the role of chromosomal abnormalities, Nucleophosmin1 mutations, and methylation-associated gene alterations in the pathogenesis and progression of acute myeloid leukaemia. This work enabled him to develop expertise in cancer cytogenetics and genomics. With over seven years of experience in cytogenetics and genomics, he joined the Jubilee Centre for Medical Research in March 2016. His current research primarily focuses on Human infertility, Polycystic ovary syndrome, Reproductive cancer, Disorders of sexual developments, Erythrocytosis, and Rare genetic disorders.
Citations-114
h-index- 7
i10-index- 3
Google scholar id: https://scholar.google.com/citations?user=auiNRtIAAAAJ&hl=en
Orcid id: https://orcid.org/0000-0001-8996-3951
Memberships
Life member, Indian association of cancer research
Life member, Indian society of human genetics
Life member, Society for Reproductive Biology and Comparative Endocrinology
Reproductive Biology
Haematological malignancies
Rare Genetic Disorders
PhD- Cancer Cytogenetics (2009-2016), Regional Cancer
Centre, Thiruvananthapuram, Kerala
M.Sc. Biotechnology (2003-2005), Kariavattom Campus,
University of Kerala, Kerala
Scientist C (Jubilee Centre for Medical Research) - Apr 2024 - Present
Scientist B2 (Jubilee Centre for Medical Research) - May 2019 - Mar 2024
Scientist B1 (Jubilee Centre for Medical Research) - Mar 2016-Apr 2019
Research Fellow (Regional Cancer Centre, Trivandrum)- Jan 2009-Feb 2016
Guest Lecturer (Dept. of Biotechnology, Kariavattom College)-Jun 2008-Jan 2009
National Educational Testing (2007), University Grants Commission, New Delhi
Junior Research Fellowship (2008), Indian Council of Medical Research, New Delhi
Ongoing Projects
1.Area: Breast
Cancer
Role - Principal
Investigator
Funding Agency- Indian Council of Medical Research (2023-2026)
Project Title: Elucidating the association of serum protein levels and genetic
polymorphisms of FABP4 with obesity and breast cancer risk in post-menopausal
obese women
Budget: INR- 84,00,000/-
2. Area: Male Infertility
Role- Principal
Investigator
Funding Agency- Department of Health Research (2023-2026)
Project Title: Elucidating the contribution of aberrant mRNAs and differentially
expressed micro RNAs of sperm RNA transcriptome to the etiopathogenesis of
idiopathic male infertility and evaluating their potentials as novel diagnostic
biomarkers
Budget: INR- 51,00,000 /-
2025
Biju J, Raveendran SK, Guruprasad KP, Reghunathan AK, George A (2025). Epigenetic Dysregulation in Idiopathic Male Infertility: The Role of Aberrant Histone Post-Translational Modifications. Reproductive Toxicology:109129.
Martin M, Rema LP, George N, Francis R, Gilvaz S, Francis J, Divya PJ, Varghese PR, Kumar RS (2025). Haplotype-based association of CYB5A gene polymorphisms (rs1790834 and rs1790858) with polycystic ovary syndrome in a south Indian cohort . Gene :149806.
Francis J, Sebastian H, Daniel S, Gilvaz S, TS Ragitha, Susan George S, Varghese L, Varghese PR, Raveendran SK (2025). Association of the MCP-1 rs1024611 Polymorphism with Polycystic Ovary Syndrome in the Indian Population. International Journal of Fertility and Sterility. 19(1):44-49.
2024
Usha K N Pai, Ragitha TS, Aboobacker Mohammed Rafi, Mithun Chacko John, Soumya Raj, Jerry Earali, Suresh Kumar Raveendran (2024). Genetic analysis of driver mutations in Classical Myeloproliferative Neoplasms- a study from South Indian tertiary care center. The Egyptian Journal of Haematology. 49(4):444-7.
2023
Ragitha TS, Sunish KS, Gilvaz S, Daniel S, Varghese PR, Raj S, Francis J, Kumar RS (2023). Mutation analysis of WNT4 gene in SRY negative 46, XX DSD patients with Mullerian agenesis and/or gonadal dysgenesis-An Indian study . Gene.861:147236.
2022
Raj TA, Gopinath P, Raj JG, Narayanan G, Nair SG, Philip DS, Raveendran S, Geetha P, Sreedharan H (2022). Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21-A comprehensive cytogenetic profiling of three cases with review of literature . Journal of Cancer Research and Therapeutics. 18(3), pp.697-703.
2019
Raveendran SK, Ramachandran L, Joseph L, Asokan AK, Raj S, George A, James J (2019). A novel SRY gene mutation c. 266 A> T (p. E89V) in a 46, XY complete gonadal dysgenesis patient. Andrologia. 51(9):e13377.
Chandran RK, Geetha N, Sakthivel KM, Kumar RS, Krishna KM, Sreedharan H. (2019). Differential gene expression changes and their implication on the disease progression in patients with Chronic Myeloid Leukemia. Blood Cells, Molecules, and Diseases. 77:51-60.
Chandran RK, Geetha N, Sakthivel KM, Kumar RS, Krishna KM, Sreedharan H (2019). Impact of Additional Chromosomal Aberrations on the Disease Progression of Chronic Myelogenous Leukemia. Frontiers in oncology. 9.
2017
Santhi S, Sangeetha V, Suresh kumar R, Sreeja L, George PS, Geetha N, Hariharan S.(2017). Risk effects of XRCC1Arg399Gln and XPD Lys751Gln gene polymorphisms in de novo acute myeloid leukemia-A study from India. Indian Journal of Biotechnology, 16(3):275-283.
2016
Sangeetha Vijay, Geetha N, Santhi sarojam, Suresh kumar Raveendran, Hariharan sreedharan.(2016). Enigmatic Inv(9): A case report on rare findings in hematological malignancies. Iran Red Crescent Med J, 18(4): e25062.
2015
Sureshkumar Raveendran, Santhi Sarojam, Sangeetha Vijay, Shruti Prem, Hariharan Sreedharan.(2015). A case report of concurrent IDH1 and NPM1 mutations in a Novel t(X;2)(q28;p22) in Acute Myeloid Leukaemia without maturation (AML-M1). Malays J Med Sci,22(5): 93-97.
Santhi Sarojam, Sureshkumar Raveendran, Sangeetha Vijay, Jayadevan Sreedharan, Geetha Narayanan, Hariharan Sreedharan.(2015). Characterization of CEBPA Mutations and Polymorphisms and their Prognostic Relevance in De Novo Acute Myeloid Leukemia Patients. Asian Pac J Cancer Prev,16(9):3785-92.
Sureshkumar Raveendran, Santhi Sarojam, Sangeetha Vijay, Aswathy Chandran Geetha, Jayadevan Sreedharan, Geetha Narayanan, Hariharan Sreedharan. (2015). Mutation Analysis of IDH1/2 Genes in Unselected De novo Acute Myeloid Leukaemia Patients in India - Identification of a Novel IDH2 Mutation. Asian Pac J Cancer Prev,16(9):4095- 101.
2014
Santhi Sarojam, Sangeetha Vijay, Suresh kumar Raveendran,Jayadevan Sreedharan, Geetha Narayanan, Hariharan Sreedharan. (2014). FLT3 Mutation as a Significant Prognostic Marker in de novo Acute Myeloid Leukemia Patients: Incidence, Distribution and Association with Cytogenetic Findings in a Study from South India. Middle East Journal of Cancer, 5(4): 185-196.
Suresh kumar Raveendran, Santhi Sarojam, Geetha Narayanan, Hariharan Sreedharan.(2014). A novel chromosomal abnormality t(9;14)(p24;q13) in B-acute lymphoblastic leukemia. Indian J Hum Genet, 20(1):79-81.
2013
Santhi Sarojam, Suresh kumar Raveendran, Geetha Narayanan, Hariharan Sreedharan. (2013). Novel t(7;10)(p22;p24) along with NPM1 mutation in patient with relapsed acute myeloid leukemia. Ann Saudi Med, 33(6): 619-622.
2012
Vijay S, Sarojam S, Raveendran S, Syamala V, Leelakumari S, Narayanan G, Hariharan S. (2012). Recurrent isochromosome 21 and multiple abnormalities in a patient suspected of having acute myeloid leukemia with eosinophilic differentiation - a rare case from South India. Chin J Cancer, 31(1):45-50.
